C Chemokine Receptor: A Potential Drug Target and Biomarker (P38417)

Target Name: Chemokine receptor

NCBI ID: P38417

Chemokine receptor

Other Name(s): Chemokine receptor

C Chemokine Receptor: A Potential Drug Target and Biomarker

Chemokine receptor (C chemokine receptor), also known as chemokine receptor 1 (CKR1), is a family of G protein-coupled receptors that play a crucial role in the regulation of cellular signaling pathways. C chemokine receptor is a subtype of chemokine receptor that is expressed in many different tissues and cells in the body. This subtype of chemokine receptor is an attractive drug target and a potential biomarker for the treatment of various diseases.

C chemokine receptor is a member of the G protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a key role in cellular signaling. GPCR is characterized by the presence of a catalytic active site, a transmembrane region, and an extracellular portion that contains a hormone-binding site. C chemokine receptor is a type of GPCR that is characterized by the presence of a unique transmembrane region that contains a single tyrosine residue.

C chemokine receptor is involved in the regulation of a wide range of cellular processes, including cell adhesion, migration, and survival. This subtype of chemokine receptor is involved in the development and maintenance of tissues and organs, including the skin, heart, and kidneys. C chemokine receptor is also involved in the regulation of inflammation and immune responses. This subtype of chemokine receptor is expressed in many different tissues and cells in the body, including immune cells, endothelial cells, and epithelial cells.

C chemokine receptor is a potential drug target for the treatment of various diseases. For example, C chemokine receptor is involved in the regulation of cancer cell growth and survival, which makes it an attractive target for cancer therapies. Additionally, C chemokine receptor is involved in the regulation of inflammation and immune responses, which makes it an attractive target for treatments for autoimmune diseases. Furthermore, C chemokine receptor is involved in the regulation of the development and maintenance of tissues and organs, which makes it an attractive target for treatments for disorders of tissue regeneration, such as tissue engineering and transplantation.

C chemokine receptor is also a potential biomarker for the treatment of various diseases. For example, C chemokine receptor is involved in the regulation of inflammation and immune responses, which makes it an attractive target for the assessment of inflammation and immune function. Additionally, C chemokine receptor is involved in the regulation of cancer cell growth and survival, which makes it an attractive target for the assessment of cancer risk and progress. Furthermore, C chemokine receptor is involved in the regulation of the development and maintenance of tissues and organs, which makes it an attractive target for the assessment of tissue regeneration and repair.

In conclusion, C chemokine receptor is a subtype of chemokine receptor that is involved in the regulation of a wide range of cellular processes. C chemokine receptor is an attractive drug target and a potential biomarker for the treatment of various diseases. Further research is needed to fully understand the role of C chemokine receptor in cellular signaling pathways and to develop effective treatments for these diseases.

Protein Name: Chemokine Receptor (nonspecified Subtype)

The "Chemokine receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Chemokine receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets